Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

• Status: Recruiting
• Trial end date: 2023-01-30
• Target enrollment: 0
• Participant gender: All

Summary

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Monastir
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• informed consent

• age >18 years

• Acute non-traumatic acute headaches

• patients treated in ED

• Magnesium sulfate and aspirin administered intravenously (IV)

Exclusion Criteria:

• Current regular use of analgesics, anticonvulsants or antidepressants

• Renal disorder with a low glomerular filtration rate (<60 ml/min)

• Neuromuscular disorder

• Pregnant woman

• Contrindication

• Allergy to NSAID

• Traumatic Headache

• Chronic headache ( headache occurring at least 15 days per month for at least 3 months)

• Hemodynamic instability